文献速递胸部技术与安全US

COVID-19住院患者肺超声表现

Lung Ultrasound Findings in Patients Hospitalized With COVID-19.
PubMed 文献 · J Ultrasound Med · 2021-03-05

两项美国医院对22例COVID-19住院患者共36次肺超声检查进行回顾性解读,仅8%正常,B线最常见(89%)。临床恶化患者双侧、前侧、侧胸实变及胸膜增厚比例更高,B线无显著差异;症状出现0-6天与14-28天异常表现患病率相似。

要点

  • 住院COVID-19患者肺超声仅8%正常,B线(89%)和实变(56%)最常见。
  • 临床恶化者双侧、前侧、侧胸实变及胸膜增厚比例显著高于未恶化者。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Lung ultrasound (LUS) can accurately diagnose several pulmonary diseases, including pneumothorax, effusion, and pneumonia. LUS may be useful in the diagnosis and management of COVID-19.

METHODS: This study was conducted at two United States hospitals from 3/21/2020 to 6/01/2020. Our inclusion criteria included hospitalized adults with COVID-19 (based on symptomatology and a confirmatory RT-PCR for SARS-CoV-2) who received a LUS. Providers used a 12-zone LUS scanning protocol. The images were interpreted by the researchers based on a pre-developed consensus document. Patients were stratified by clinical deterioration (defined as either ICU admission, invasive mechanical ventilation, or death within 28 days from the initial symptom onset) and time from symptom onset to their scan.

RESULTS: N = 22 patients (N = 36 scans) were included. Eleven (50%) patients experienced clinical deterioration. Among N = 36 scans, only 3 (8%) were classified as normal. The remaining scans demonstrated B-lines (89%), consolidations (56%), pleural thickening (47%), and pleural effusion (11%). Scans from patients with clinical deterioration demonstrated higher percentages of bilateral consolidations (50 versus 15%; P = .033), anterior consolidations (47 versus 11%; P = .047), lateral consolidations (71 versus 29%; P = .030), pleural thickening (69 versus 30%; P = .045), but not B-lines (100 versus 80%; P = .11). Abnormal findings had similar prevalences between scans collected 0-6 days and 14-28 days from symptom onset.

DISCUSSION: Certain LUS findings may be common in hospitalized COVID-19 patients, especially for those that experience clinical deterioration. These findings may occur anytime throughout the first 28 days of illness. Future efforts should investigate the predictive utility of these findings on clinical outcomes.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Kumar A, Weng Y, Duanmu Y, et al. Lung Ultrasound Findings in Patients Hospitalized With COVID-19. J Ultrasound Med. 2021. PMID: 33665872. doi:10.1002/jum.15683

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。